메뉴 건너뛰기




Volumn 286, Issue 7, 2001, Pages 815-820

Bone mineral density response to estrogen replacement in frail elderly women; A randomized controlled trial

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; PEPTIDE HORMONE; PLACEBO;

EID: 0035880311     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.7.815     Document Type: Article
Times cited : (75)

References (40)
  • 19
    • 0029028408 scopus 로고
    • Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women
    • (1995) Osteoporos Int , vol.5 , pp. 150-155
    • Kohrt, W.M.1    Birge, S.J.2
  • 21
    • 0029907556 scopus 로고    scopus 로고
    • Effects of hormone therapy on bone mineral density: Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
    • (1996) JAMA , vol.276 , pp. 1389-1396
  • 27
    • 0030883779 scopus 로고    scopus 로고
    • Osteoporosis: Trials and tribulations
    • (1997) Am J Med , vol.103 , pp. 74S-87S
    • Seeman, E.1
  • 33
    • 0031955217 scopus 로고    scopus 로고
    • A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
    • (1998) J Bone Miner Res , vol.13 , pp. 763-773
    • Riggs, B.L.1    Khosla, S.2    Melton, L.J.3
  • 39
    • 0030983956 scopus 로고    scopus 로고
    • Prevention of hip fractures: Risk factor modification
    • (1997) Am J Med , vol.103 , pp. 65S-71S
    • Slemenda, C.1
  • 40
    • 0032919277 scopus 로고    scopus 로고
    • Risk factors for hip fracture not related to bone mass and their therapeutic implications
    • (1999) Osteoporos Int , vol.9 , pp. S9-S16
    • Allolio, B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.